Studies in the area of synovial sarcoma reported from University of Groningen

"The aim of this study was to investigate prognostic factors influencing, the survival of synovial sarcoma, including the debated role of SYT-SSX fusion type and the newly Suggested immunohistochemical marker ezrin. Patients and,Methods: From 1984 to 2005, 45 patients-25 men (56%) and 20 women (44%) with a median age of 31 (range: 2 to 81) years-were diagnosed with a synovial sarcoma. Age at diagnosis. tumor Site, tumor size, tumor histology (biphasic vs. monophasic), Mitotic Count, necrosis, histologic grade, SYT-SSX fusion type, and ezrin immunostaining were analyzed for influence on survival by univariate and multivariate methods," scientists in Netherlands report.

...

Want to see the full article?

• Purchase this article for only $3.00